Amgen Stock: Strive Financial Group Trims Stake by Nearly 70%

Strive Financial Group LLC sold 4,466 shares of Amgen Inc. (NASDAQ:AMGN) during the second quarter, trimming its stake in the medical research company by 69.5%. As a result, the fund owned 1,957 shares worth $709,000 as of its most recent SEC filing.

The institutional investors and hedge funds that own shares of Amgen include Strive Financial Group LLC, Dogwood Wealth Management LLC, Anfield Capital Management LLC, Tower View Wealth Management LLC, Manning & Napier Advisors LLC, and Ares Financial Consulting LLC. These entities collectively own 76.50% of the company's stock.

Insiders at Amgen have also made significant transactions in recent months. SVP Nancy A. Grygiel sold 2,970 shares on August 6th, while SVP Rachna Khosla sold 1,252 shares on August 13th. These sales represented a total of $2,540,926.

Amgen's stock opened at $415.21 on Friday and has a market capitalization of $224.47 billion. The company has a PE ratio of 25.81, a price-to-earnings-growth ratio of 3.86, and a beta of 0.41.